Julian Gill
Medical Reporter at Houston Chronicle
Medical reporter @houstonchron. Writing. Running. Music. SA Spurs. News tips? [email protected]
Articles
-
2 weeks ago |
houstonchronicle.com | Julian Gill
Baylor College of Medicine is laying off 122 employees as it prepares for major federal funding cuts from the Trump administration, the school announced Wednesday. While the layoffs affect less than 1% of Baylor's roughly 13,000-member workforce, they speak to the vulnerability of academic medical centers nationwide amid the proposed cuts to a range of federal health care services.
-
2 weeks ago |
houstonchronicle.com | Julian Gill
MD Anderson Cancer Center has implemented a hiring pause for some positions and cut back “non-essential” spending after seeing a budget shortfall through the first half of the fiscal year, according to an internal email from the cancer center’s president, Dr. Peter Pisters. In the email, sent to employees April 17, Pisters said the cancer center took a $43 million operating loss through March – or $18.3 million below projections.
-
3 weeks ago |
houstonchronicle.com | Julian Gill
If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a patient’s specific needs. Some patients might need a dosage that isn’t commercially available, or they might need a liquid form of a medication only sold as a pill. For these drugs, hospitals, doctors and telemedicine providers commonly turn to compounding pharmacies.
-
3 weeks ago |
houstonchronicle.com | Julian Gill
Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound, on April 1 sued the Houston-based Empower Pharmacy, accusing the company of conducting a “mass testing experiment” on the public by selling "knockoff" versions of their drugs that have never been reviewed for quality and safety.
-
1 month ago |
houstonchronicle.com | Julian Gill
Memorial Hermann Health System is reactivating its liver transplant program, one year after a surgeon's improper data manipulations prompted the hospital to stop all abdominal transplant operations, the health system announced Saturday. Dr. Mark Hobeika, a former transplant surgeon at Houston Methodist Hospital, will take over as the hospital's abdominal transplant program director and chief of immunology and organ transplantation at UTHealth Houston, the hospital system said.
Journalists covering the same region
Melissa Cantu Trevino
Managing Editor at Alice Echo-News Journal
Melissa Cantu Trevino primarily covers news in the South Texas region, including areas around Karnes City and San Antonio, Texas, United States.
Chris Thomasson
Sports Director at KIII-TV (Corpus Christi, TX)
Chris Thomasson primarily covers news in the Coastal Bend region of Texas, United States, including areas around Corpus Christi.
Alexis Scott
Reporter at KRIS-TV (Corpus Christi, TX)
Alexis Scott primarily covers news in Corpus Christi, Texas, United States and surrounding areas.
Judith Rayo
Journalist at KLDO-TV (Laredo, TX)
Judith Rayo primarily covers news in Laredo, Texas, United States and surrounding areas.
César Rodríguez
Editor at Universo digital Noticias
César Rodríguez primarily covers news in the South Texas region, including areas around Laredo and San Antonio, Texas, United States.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 3K
- Tweets
- 8K
- DMs Open
- Yes
RT @JustJhair: 🥳 I'm officially taking over @HoustonChron's Houston Explained product, please follow along! https://t.co/cXhxhmYS9Z
NEW: MD Anderson implements hiring pause after $43M loss, anxiety over Trump tariffs https://t.co/JAfVDR1M4I via @houstonchron
NEW: Eli Lilly is suing the Houston-based Empower Pharmacy over wildly popular diabetes and weight loss drugs, arguing the company is falsely advertising “personalized” products that are actually mass produced. https://t.co/D0cnBFqELK via @houstonchron